NCT02737007 - A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 18, 2016

Primary Completion Date

May 12, 2016

Study Completion Date

May 12, 2016

Conditions

Malaria, Falciparum

Interventions

DRUG

[14C]-GSK3191607

\[14C\]-GSK3191607 is a solution to be administered intravenously as a single dose infusion over 15 minutes. It is a radio-labeled product; 100 mcg of \[14C\]-GSK3191607 contains approximately 7.4 kilobecquerel (kBq) of \[14C\] radioactivity.

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London